other
confidence high
sentiment neutral
materiality 0.60
Aligos stockholders approve charter amendments increasing authorized shares 5x and 2020 Plan share reserve by 1M
Aligos Therapeutics, Inc.
- Stockholders approved increase in authorized voting common stock from 20M to 100M shares.
- Stockholders approved increase in authorized non-voting common stock from 800k to 15.8M shares.
- Stockholders approved amendment to 2020 Plan adding 1M shares to the share reserve.
- All three Class II director nominees (Hirth, Preston, Chavez) were elected with ~2.16M votes for.
- Ratification of Ernst & Young as independent auditor for FY2025 approved with 3.43M votes for.
item 5.02item 5.07item 5.03item 9.01